Fig. 4From: Discovery and validation of tissue-specific DNA methylation as noninvasive diagnostic markers for colorectal cancerComparison of tissue-specific methylation markers with previously commercial methylation markers. Heatmap shows misclassification rate of 10 CpG sites from our study and 15 CpG sites from three commercial biomarkers in distinguishing CRC samples from ten other cancer types in TCGA dataset. Numbers represent the misclassification rate of predicted CRC in non-CRC tumor (T) and non-CRC normal (N) samplesBack to article page